Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Randy D Blakely

Showing results (21-30 of 224) with videos related to

Pageof 23
Sort By:
Molecular and Cellular Neurosciences|December 31, 2003
Cell surface trafficking of the antidepressant-sensitive norepinephrine transporter revealed with an ectodomain antibodyValentina Savchenko, Uhna Sung, Randy D Blakely
Neuropharmacology|October 11, 2005
Expression studies of naturally occurring human dopamine transporter variants identifies a novel state of transporter inactivation associated with Val382AlaMichelle S Mazei-Robison, Randy D Blakely
Biochemical Pharmacology|August 14, 2013
Choline transporter hemizygosity results in diminished basal extracellular dopamine levels in nucleus accumbens and blunts dopamine elevations following cocaine or nicotineYu Dong, John A Dani, Randy D Blakely
Neurochemistry International|April 23, 2014
The brain in flux: genetic, physiologic, and therapeutic perspectives on transporters in the CNSRandy D Blakely, Arturo Ortega, Michael B Robinson
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 14, 2003
A mutation in the human norepinephrine transporter gene (SLC6A2) associated with orthostatic intolerance disrupts surface expression of mutant and wild-type transportersMaureen K Hahn, David Robertson, Randy D Blakely
Neurochemistry International|March 26, 2016
Differential impact of genetically modulated choline transporter expression on the release of endogenous versus newly synthesized acetylcholineHideki Iwamoto, M Wade Calcutt, Randy D Blakely
Proceedings of the National Academy of Sciences of the United States of America|September 5, 2008
Dopamine transporter/syntaxin 1A interactions regulate transporter channel activity and dopaminergic synaptic transmissionLucia Carvelli, Randy D Blakely, Louis J DeFelice
Physiology (Bethesda, Md.)|July 19, 2005
Biogenic amine neurotransmitter transporters: just when you thought you knew themRandy D Blakely, Louis J DeFelice, Aurelio Galli
Neurochemistry International|November 16, 2013
Good riddance to dopamine: roles for the dopamine transporter in synaptic function and dopamine-associated brain disordersRaajaram Gowrishankar, Maureen K Hahn, Randy D Blakely
Molecular Interventions|January 18, 2008
Bound to be different: neurotransmitter transporters meet their bacterial cousinsL Keith Henry, Jens Meiler, Randy D Blakely
Pageof 23

Showing results (21-30 of 224) with videos related to

Sort By:
Pageof 23
Molecular and Cellular Neurosciences|December 31, 2003
Cell surface trafficking of the antidepressant-sensitive norepinephrine transporter revealed with an ectodomain antibodyValentina Savchenko, Uhna Sung, Randy D Blakely
Neuropharmacology|October 11, 2005
Expression studies of naturally occurring human dopamine transporter variants identifies a novel state of transporter inactivation associated with Val382AlaMichelle S Mazei-Robison, Randy D Blakely
Biochemical Pharmacology|August 14, 2013
Choline transporter hemizygosity results in diminished basal extracellular dopamine levels in nucleus accumbens and blunts dopamine elevations following cocaine or nicotineYu Dong, John A Dani, Randy D Blakely
Neurochemistry International|April 23, 2014
The brain in flux: genetic, physiologic, and therapeutic perspectives on transporters in the CNSRandy D Blakely, Arturo Ortega, Michael B Robinson
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 14, 2003
A mutation in the human norepinephrine transporter gene (SLC6A2) associated with orthostatic intolerance disrupts surface expression of mutant and wild-type transportersMaureen K Hahn, David Robertson, Randy D Blakely
Neurochemistry International|March 26, 2016
Differential impact of genetically modulated choline transporter expression on the release of endogenous versus newly synthesized acetylcholineHideki Iwamoto, M Wade Calcutt, Randy D Blakely
Proceedings of the National Academy of Sciences of the United States of America|September 5, 2008
Dopamine transporter/syntaxin 1A interactions regulate transporter channel activity and dopaminergic synaptic transmissionLucia Carvelli, Randy D Blakely, Louis J DeFelice
Physiology (Bethesda, Md.)|July 19, 2005
Biogenic amine neurotransmitter transporters: just when you thought you knew themRandy D Blakely, Louis J DeFelice, Aurelio Galli
Neurochemistry International|November 16, 2013
Good riddance to dopamine: roles for the dopamine transporter in synaptic function and dopamine-associated brain disordersRaajaram Gowrishankar, Maureen K Hahn, Randy D Blakely
Molecular Interventions|January 18, 2008
Bound to be different: neurotransmitter transporters meet their bacterial cousinsL Keith Henry, Jens Meiler, Randy D Blakely
Pageof 23